Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy C Hicks

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2015
Metabonomics and diagnosticsLucy C Hicks, Simon J L Ralphs, Horace R T Williams
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 2, 2024
Faecal calprotectin in primary care: is its current use supported by the evidence?Robert W Perry, David Mummery, James L Alexander, et al.
Journal of Crohn'S & Colitis|June 14, 2015
Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot StudyLucy C Hicks, Juzheng Huang, Sacheen Kumar, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 4, 2025
From bedside to bench: Evaluating the effect of different storage and extraction techniques on protease activity analysis in inflammatory bowel disease patientsRobert W Perry, Frederic Buemi, Xinyu Guo, et al.
Alimentary Pharmacology & Therapeutics|November 9, 2021
Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel diseaseShiva T Radhakrishnan, James L Alexander, Benjamin H Mullish, et al.
Inflammatory Bowel Diseases|May 8, 2026
Disease phenotype affects treatment of late-onset inflammatory bowel disease: Analysis of a large UK cohortPeter F G Foulser, Laura Martinez-Gili, Sharmili Balarajah, et al.
Eclinicalmedicine|January 7, 2026
A large-scale comparison of clinical outcomes to IBD therapies in White and South Asian ethnicitiesSharmili Balarajah, Laura Martinez-Gili, James L Alexander, et al.
BMC Gastroenterology|May 13, 2022
Effects of bowel preparation on intestinal bacterial associated urine and faecal metabolites and the associated faecal microbiomeSam T R Powles, Kate I Gallagher, Leo W L Chong, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2021
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control studyShaji Sebastian, Gareth J Walker, Nicholas A Kennedy, et al.
Alimentary Pharmacology & Therapeutics|May 7, 2021
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort studyChristopher A Lamb, Shaji Sebastian, Alexandra J Kent, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2015
Metabonomics and diagnosticsLucy C Hicks, Simon J L Ralphs, Horace R T Williams
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 2, 2024
Faecal calprotectin in primary care: is its current use supported by the evidence?Robert W Perry, David Mummery, James L Alexander, et al.
Journal of Crohn'S & Colitis|June 14, 2015
Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot StudyLucy C Hicks, Juzheng Huang, Sacheen Kumar, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 4, 2025
From bedside to bench: Evaluating the effect of different storage and extraction techniques on protease activity analysis in inflammatory bowel disease patientsRobert W Perry, Frederic Buemi, Xinyu Guo, et al.
Alimentary Pharmacology & Therapeutics|November 9, 2021
Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel diseaseShiva T Radhakrishnan, James L Alexander, Benjamin H Mullish, et al.
Inflammatory Bowel Diseases|May 8, 2026
Disease phenotype affects treatment of late-onset inflammatory bowel disease: Analysis of a large UK cohortPeter F G Foulser, Laura Martinez-Gili, Sharmili Balarajah, et al.
Eclinicalmedicine|January 7, 2026
A large-scale comparison of clinical outcomes to IBD therapies in White and South Asian ethnicitiesSharmili Balarajah, Laura Martinez-Gili, James L Alexander, et al.
BMC Gastroenterology|May 13, 2022
Effects of bowel preparation on intestinal bacterial associated urine and faecal metabolites and the associated faecal microbiomeSam T R Powles, Kate I Gallagher, Leo W L Chong, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2021
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control studyShaji Sebastian, Gareth J Walker, Nicholas A Kennedy, et al.
Alimentary Pharmacology & Therapeutics|May 7, 2021
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort studyChristopher A Lamb, Shaji Sebastian, Alexandra J Kent, et al.
Pageof 2